Corrigendum to 'Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study' [J Hepatol 67 (2017) 940-949]

Christophe Bureau¹, Danielle Adebayo², Mael Chalret de Rieu¹, Laure Elkrief³, Dominique Valla³, Markus Peck-Radosavljevic⁴, Anne McCune⁵, Victor Vargas⁶, Macarena Simon-Talero⁶, Juan Cordoba⁶, Paolo Angeli⁷, Silvia Rosi⁷, Stewart MacDonald², Massimo Malago⁸, Maria Stepanova⁹, Zobair M Younossi¹⁰, Claudia Trepte¹¹, Randall Watson¹², Oleg Borisenko¹³, Sun Sun¹⁴, Neil Inhaber¹¹, Rajiv Jalan¹⁵

Affiliations

¹ Service d'hépato-gastroentérologie, CHU Toulouse, Toulouse, France.
² UCL Institute of Hepatology, Royal Free Hospital, University College London, London, United Kingdom.
³ DHU UNITY, Service d'hépatologie, Hôpital Beaujon, Clichy and Université Paris Diderot and Inserm U1149, Paris, France.
⁴ Department of Gastroenterology/Hepatology, Endocrinology and Nephrology, Klinikum Klagenfurt am Wörthersee, Klagenfurt, Austria.
⁵ Department of Hepatology, Bristol Royal Infirmary, Bristol, United Kingdom.
⁶ Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d'Hebron, VHIR, Universitat Autònoma de Barcelona, CIBERehd, Barcelona, Spain.
⁷ Facoltà di Medicina e Chirurgia, Università degli Studi di Padova, Padova, Italy.
⁸ Hepato-pancreatic-biliary and Liver Transplantation Surgery, Royal Free Hospital, University College London, London, United Kingdom.
⁹ Center for Outcomes Research in Liver Disease, Washington DC.
¹⁰ Department of Medicine, Inova Fairfax Hospital, Falls Church, VA.
¹¹ Sequana Medical AG, Zurich, Switzerland.
¹² Medicalwriters.com, Zurich, Switzerland.
¹³ Synergus AB, Danderyd, Sweden.
¹⁴ Synergus AB, Danderyd, Sweden; Health Outcomes and Economic Evaluation Research Group, Department of Learning, Information, Management and Ethics, Karolinska Institutet, Stockholm, Sweden and Division of Epidemiology and Global Health, Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
¹⁵ UCL Institute of Hepatology, Royal Free Hospital, University College London, London, United Kingdom. Electronic address: r.jalan@ucl.ac.uk.

PMID: 31928862
DOI: 10.1016/j.jhep.2019.11.023

Published Erratum

Corrigendum to 'Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study' [J Hepatol 67 (2017) 940-949]

Christophe Bureau et al. J Hepatol. 2020 Mar.

. 2020 Mar;72(3):595-596.

doi: 10.1016/j.jhep.2019.11.023. Epub 2020 Jan 9.

Authors

Affiliations

¹ Service d'hépato-gastroentérologie, CHU Toulouse, Toulouse, France.
² UCL Institute of Hepatology, Royal Free Hospital, University College London, London, United Kingdom.
³ DHU UNITY, Service d'hépatologie, Hôpital Beaujon, Clichy and Université Paris Diderot and Inserm U1149, Paris, France.
⁴ Department of Gastroenterology/Hepatology, Endocrinology and Nephrology, Klinikum Klagenfurt am Wörthersee, Klagenfurt, Austria.
⁵ Department of Hepatology, Bristol Royal Infirmary, Bristol, United Kingdom.
⁶ Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d'Hebron, VHIR, Universitat Autònoma de Barcelona, CIBERehd, Barcelona, Spain.
⁷ Facoltà di Medicina e Chirurgia, Università degli Studi di Padova, Padova, Italy.
⁸ Hepato-pancreatic-biliary and Liver Transplantation Surgery, Royal Free Hospital, University College London, London, United Kingdom.
⁹ Center for Outcomes Research in Liver Disease, Washington DC.
¹⁰ Department of Medicine, Inova Fairfax Hospital, Falls Church, VA.
¹¹ Sequana Medical AG, Zurich, Switzerland.
¹² Medicalwriters.com, Zurich, Switzerland.
¹³ Synergus AB, Danderyd, Sweden.
¹⁴ Synergus AB, Danderyd, Sweden; Health Outcomes and Economic Evaluation Research Group, Department of Learning, Information, Management and Ethics, Karolinska Institutet, Stockholm, Sweden and Division of Epidemiology and Global Health, Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
¹⁵ UCL Institute of Hepatology, Royal Free Hospital, University College London, London, United Kingdom. Electronic address: r.jalan@ucl.ac.uk.

PMID: 31928862
DOI: 10.1016/j.jhep.2019.11.023

No abstract available

PubMed Disclaimer

Erratum for

Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study.
Bureau C, Adebayo D, Chalret de Rieu M, Elkrief L, Valla D, Peck-Radosavljevic M, McCune A, Vargas V, Simon-Talero M, Cordoba J, Angeli P, Rosi S, MacDonald S, Malago M, Stepanova M, Younossi ZM, Trepte C, Watson R, Borisenko O, Sun S, Inhaber N, Jalan R. Bureau C, et al. J Hepatol. 2017 Nov;67(5):940-949. doi: 10.1016/j.jhep.2017.06.010. Epub 2017 Jun 21. J Hepatol. 2017. PMID: 28645737 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Corrigendum to 'Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study' [J Hepatol 67 (2017) 940-949]

Affiliations

Corrigendum to 'Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study' [J Hepatol 67 (2017) 940-949]

Authors

Affiliations

Erratum for

Publication types

LinkOut - more resources

Full Text Sources